1. Academic Validation
  2. Inhibition of DYRK1A and GSK3B induces human β-cell proliferation

Inhibition of DYRK1A and GSK3B induces human β-cell proliferation

  • Nat Commun. 2015 Oct 26;6:8372. doi: 10.1038/ncomms9372.
Weijun Shen 1 Brandon Taylor 1 Qihui Jin 1 Van Nguyen-Tran 1 Shelly Meeusen 1 You-Qing Zhang 1 Anwesh Kamireddy 1 Austin Swafford 1 Andrew F Powers 1 John Walker 1 John Lamb 1 Badry Bursalaya 1 Michael DiDonato 1 George Harb 1 Minhua Qiu 1 Christophe M Filippi 1 Lisa Deaton 1 Carolina N Turk 1 Wilma L Suarez-Pinzon 2 Yahu Liu 1 Xueshi Hao 1 Tingting Mo 1 Shanshan Yan 1 Jing Li 1 Ann E Herman 1 Bernhard J Hering 2 Tom Wu 1 H Martin Seidel 1 Peter McNamara 1 Richard Glynne 1 Bryan Laffitte 1
Affiliations

Affiliations

  • 1 Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, USA.
  • 2 Department of Surgery and Schulze Diabetes Institute, University of Minnesota, 420 Delaware Street SE, Minneapolis, Minnesota 55455, USA.
Abstract

Insufficient pancreatic β-cell mass or function results in diabetes mellitus. While significant progress has been made in regulating Insulin secretion from β-cells in diabetic patients, no pharmacological agents have been described that increase β-cell replication in humans. Here we report aminopyrazine compounds that stimulate robust β-cell proliferation in adult primary islets, most likely as a result of combined inhibition of DYRK1A and GSK3B. Aminopyrazine-treated human islets retain functionality in vitro and after transplantation into diabetic mice. Oral dosing of these compounds in diabetic mice induces β-cell proliferation, increases β-cell mass and Insulin content, and improves glycaemic control. Biochemical, genetic and Cell Biology data point to Dyrk1a as the key molecular target. This study supports the feasibility of treating diabetes with an oral therapy to restore β-cell mass, and highlights a tractable pathway for future drug discovery efforts.

Figures
Products
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》